• Screening of patients in New Zealand improved after visiting the clinical centres involved in SER150 CL-009 study.
• The broaden of inclusion criteria for recruitment of patients to the
  SER150 CL-009 study is about to be approved by both health
  authorities and the individual clinical centres.
• The company raised app. NOK 17 M in a Private Placement.

Read more here